ADAC's Lowe passes CEO title to Eckert
ADAC Laboratories has added CEO to Andrew Eckert's list of titles, which already includes president and COO. Giving up the CEO mantle is David Lowe, who will remain chairman of the Milpitas, CA, nuclear medicine vendor. ADAC said the transition was part
ADAC Laboratories has added CEO to Andrew Eckert's list of titles, which already includes president and COO. Giving up the CEO mantle is David Lowe, who will remain chairman of the Milpitas, CA, nuclear medicine vendor. ADAC said the transition was part of a long-planned management development strategy, and that Lowe will continue to develop the company's strategic and operating plans.
In other ADAC news, the company signed an agreement to provide multivendor service and support of gamma cameras to customers in the asset management program of independent service organization COHR. The agreement will add over 75 gamma cameras to ADAC's multivendor service effort, which ADAC began in 1995 with the acquisition of JD Technical Services (SCAN 12/13/95).
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
